Chinese Herbal Formula Ermiao Powder () Regulates Cholinergic Anti-inflammatory Pathway in Rats with Rheumatoid Arthritis.
10.1007/s11655-020-3471-2
- Author:
Zhen LI
1
;
Jin LIU
2
;
Hui-Qin HAO
3
;
Yu-Ting GAO
2
;
Ze WANG
2
Author Information
1. College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, (030619), Shanxi Province, China.
2. Basic Laboratory of Integrated Traditional Chinese and Western Me, Shanxi University of Chinese Medicine, Jinzhong, 030619, China.
3. College of Basic Medical Sciences, Shanxi University of Chinese Medicine, Jinzhong, (030619), Shanxi Province, China. 13934160790@163.com.
- Publication Type:Journal Article
- Keywords:
CHRNA7;
Chinese medicine;
Ermiao Powder;
rheumatoid arthritis;
α7nAchR
- From:
Chinese journal of integrative medicine
2020;26(12):905-912
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the effect of Chinese herbal formula Ermiao Powder (, EMP) on the expression of cholinergic anti-inflammatory pathway in rats with rheumatoid arthritis (RA).
METHODS:Seventy-two rats were randomly divided into 6 groups according to body weight, including normal control group, collageninduced arthritis (CIA) group, three doses EMP groups, and methotrexate (MTX) group (n=12 per group). All of the rats except for those in the normal control group were given multipoint subcutaneous injection of bovine type II collagen to establish a CIA model. Three EMP groups received a high- (4.5 g/kg), medium- (3.0 g/kg), and low- (1.5 g/kg) doses of EMP by intragavage, respectively. MTX group was injected intraperitoneally MTX at 0.9 mg/kg once a week as the positive control. The administration was 3 consecutive weeks. Joint swelling, arthritis index, and body weight changes in different experimental groups of rats were tested. The joint damage was evaluated by masson staining. Quantitative real-time polymerase chain reaction, Western blot, and immunohistochemistry (IHC) were performed to evaluate the expression of CHRNA7, encoding α7 nicotinic acetylcholine receptor in the cholinergic anti-inflammatory pathway, in different tissues and their localization in the spleen and joints.
RESULTS:CHRNA7 expression levels were significantly higher in the joints and spleens of CIA group than those in normal control group (both P<0.05). Moreover, the CHRNA7 mRNA and protein levels in the spleen and joints of MTX and three doses of EMP groups were significantly lower than CIA group (all P<0.05). Compared with the MTX group, treatment with low-dose EMP resulted in significant reduction of CHRNA7 mRNA and protein expression levels (P<0.05 or P<0.01). IHC showed positive signals of CHRNA7 in the white pulp and red pulp of the spleens of rats; CHRNA7 was expressed on fibroblast-like synoviocytes, macrophages, and endothelial cells in the joints of rats, and the expression in the joints of low-dose EMP group was significantly lower than that in the CIA group (P<0.01).
CONCLUSIONS:Cholinergic anti-inflammatory pathway was involved in the generation of the inflammatory reaction in CIA rats, and EMP exerted therapeutic effect on RA through cholinergic anti-inflammatory pathway.
